The primary purpose of collecting adverse event information is to assess the safety of the investigational product. Adverse events may indicate potential risks or side effects associated with the use of the product. By systematically collecting and analyzing adverse event data, researchers can evaluate the safety profile of the investigational product and identify any safety concerns or potential risks.
MedDRA is a standardized medical terminology specifically designed for the classification and coding of adverse events. Using MedDRA coding allows for consistent and uniform reporting of adverse events across different clinical trials and facilitates the comparison and analysis of safety data.
By employing a standardized coding system like MedDRA, adverse events can be categorized and classified based on their specific medical terms, organ systems affected, and severity levels.
General Adverse Events: These are the common adverse events that can occur in the study population and are expected based on the known safety profile of the investigational product or the underlying condition being studied. General adverse events include symptoms, signs, or diseases that are not specifically targeted or focused on in the study protocol. Examples of general adverse events can include headache, nausea, fatigue, or mild laboratory abnormalities.
Adverse Events of Special Interest: These are adverse events that are of particular interest to the study because they may be related to the investigational product or have specific clinical significance. Adverse events of special interest are usually pre-specified in the study protocol and are carefully monitored and analyzed throughout the trial. These events may be known risks associated with the product or could be potential safety concerns that require further investigation. Examples of adverse events of special interest can include serious cardiovascular events, severe infections, or specific organ toxicities.